Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety practice in developing countries varies substantially from country to country. This can lead to a rise in adverse reactions and a lack of reporting can exasperate the situation and lead to negative medical outcomes. This book documents the history and development of drug safety systems, pharmacovigilance centers and activities in developing countries, describing their current situation and achievements of drug safety practice. Further, using extensive case studies, the book addresses the challenges of drug safety in developing countries.
Rezensionen / Stimmen
"This book offers a unique perspective on drug safety issues in developing countries and a comparison of different aspects including pharmacovigilance, medication errors, counterfeit medications, abuse, and storage and disposal. It highlights achievements and challenges for drug safety issues in over 21 countries and offers solutions to overcome these barriers. The significance of this book allows readers to understand how these drug safety challenges in developing countries can be improved to reduce adverse drug events to lower morbidity and mortality." --Doody Reviews
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science Publishing Co Inc
Zielgruppe
Für Beruf und Forschung
<b>Primary</b>: Researchers and advanced students in biomedical sciences, cell biology, physiology, pathology and pharmacology.
<b>
Secondary:</b> Clinicians and pathologists interested in tissue barrier diseases.
Maße
Höhe: 276 mm
Breite: 216 mm
Gewicht
ISBN-13
978-0-12-819837-7 (9780128198377)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Prof. Yaser Mohammed Al-Worafi is a Professor of Clinical Pharmacy at the College of Pharmacy, University of Science and Technology of Fujairah, UAE (Previously known as Ajman University). He graduated with a bachelor's degree in Pharmacy (BPharm) from Sana'a University, Yemen and obtained a Master and PhD degree in Clinical Pharmacy from the Universiti Sains Malaysia (USM), Malaysia. He has more than 20 years experience in education, practice and research in Yemen, Saudi Arabia, United Arab Emirates and Malaysia. He has held various academic and professional positions including Deputy Dean for Medical Sciences College; PharmD program director, Head of Clinical Pharmacy/Pharmacy Practice department; Head of Teaching & learning committee, Head of Training Committee, head of the curriculum committee and other committees. He has authored over 100 peer-reviewed papers in international journals, and book chapters and edited more than 10 books by Elsevier, Springer, Taylors & Francis, USA. Prof.Yaser has supervised/co-supervised many PhD, Master, PharmD and B-Pharm students. He is a reviewer for eight recognized international peer-reviewed journals. Prof. Yaser prepared, designed, and wrote many pharmacy programs for many universities including Master of Clinical Pharmacy/Pharmacy Practice program; PharmD program and BPharm program; internship/clerkships for Master, PharmD and BPharm programs; more than 30 courses related to Clinical Pharmacy, Pharmacy Practice, Social Pharmacy and Patients care.
Herausgeber*in
Professor of Clinical Pharmacy, College of Pharmacy, University of Science and Technology of Fujairah, Fujairah, United Arab Emirates; Deputy Dean and Professor, College of Medical Sciences, Azal University for Human Development, Sana'a, Yemen.
Section 1 Drug safety-related issues
1. Introduction: Why do we need a book on drug safety in developing countries?
2. Medications safety-related terminology
3. Medications registration and marketing: safety-related issues
4. Pharmacovigilance
5. Adverse drug reactions
6. Medication errors
7. Self-medication
8. Antibiotics safety issue
9. Drug-related problems
10. Counterfeit and substandard medications
11. Medication abuse and misuse
12. Storage and disposal of medications
13. Safety of medications in special population
14. Herbal medicines safety issues
15. Medications safety resources and tools
16. Medications safety pharmacoeconomics-related issues
17. Evidence-based medications safety practice
18. Technology in medications safety
19. Medications safety research issues
20. Quality indicators for medications safety
Section 2: Drug Safety in Asia
21. Drug safety in Malaysia
22. Drug safety in Thailand
23. Drug safety in Indonesia
24. Drug safety in Pakistan
25. Drug safety in India
26. Drug safety in Nepal
27. Drug safety in Sri Lanka
28. Drug Safety in China
Section 3: Drug Safety in Middle East
29. Drug safety in Yemen
30. Drug safety in Saudi Arabia
31. Drug safety in UAE
32. Drug safety in Jordan
33. Drug safety in Lebanon
34. Drug safety in Palestine
35. Drug safety in Qatar
Section 4: Drug Safety in Africa
36. Drug safety in Sudan
37. Drug safety in Egypt
38. Drug safety in Nigeria
39. Drug safety in Mali
40. Drug safety in Burkina Faso
Section 5: Drug Safety in Latin America
41. Drug safety in Chile
Section 6: Comparisons and conclusions
42. Compare between the developing countries
43. Drug Safety in Developing Versus Developed countries
